PortView
Invesco Biotechnology & Genome (PBE) ETF Holdings & Analysis
ETFOther
What PBE does
The Invesco Biotechnology & Genome ETF (PBE) seeks to replicate the performance of the Dynamic Biotech & Genome Intellidex Index. This fund typically allocates a minimum of 90% of its total assets to the securities comprising the underlying index. The Index is constructed to achieve capital appreciation by thoroughly evaluating companies based on several investment criteria, including their price momentum, earnings growth, overall quality, management decisions, and valuation. It consists of 30 U.S.-based companies within the biotechnology and genome sectors. These companies are primarily involved in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, or they are businesses that stand to gain significantly from scientific and technological breakthroughs in biotechnology and genetic engineering. Both the ETF and its benchmark index undergo quarterly rebalancing and reconstitution in February, May, August, and November.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| Amgen Inc | 5.47% | |
| Regeneron Pharmaceuticals Inc | 5.44% | |
| Vertex Pharmaceuticals Inc | 5.29% | |
| CareDx Inc | 5.21% | |
| Royalty Pharma PLC | 4.86% | |
| Gilead Sciences Inc | 4.71% | |
| Biogen Inc | 4.70% | |
| United Therapeutics Corp | 3.71% | |
| Omeros Corp | 3.69% | |
| Halozyme Therapeutics Inc | 3.59% |
Sector allocation
| Cash & Others | 0.00% |
| Financial Services | 0.02% |
| Healthcare | 99.98% |
Geographic allocation
| United States | 97.20% |
| Netherlands | 2.78% |
| Other | 0.02% |
PortView Portfolio Insights
PortView analyzes how PBE fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze PBE in PortView →Related securities
Related stocks
Frequently asked questions
- What does PBE track?
- PBE is the Invesco Biotechnology & Genome ETF, a Other ETF.
- What is the expense ratio of PBE?
- Expense ratio data for PBE is shown on the page when available from our data provider.
- What are the largest holdings in PBE?
- Top holdings include AMGN, REGN, VRTX, CDNA, RPRX.
- How can PortView analyze PBE overlap with other ETFs?
- PortView computes the holdings overlap between PBE and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.